CG Oncology, Inc.
CGONBiotechnology
$63.47−0.77%As of Oct 29vs prior close
- Market cap
- $5.6B
- P/E (TTM)
- –
- From 52W high
- −21.33%
- EPS (LTM)
- -$2.70
- Revenue (LTM)
- $6.2M
- Net margin
- -3602.68%
- Dividend yield
- 0.00%
Nomior Score
56
Steady ProfileSpeculativeTop 36% of the scored universe
Growth60
Quality38
Value45
Momentum89
Resilience37
Growth
+345.02%revenue a year over 2 fiscal years
YE23 $204KLTM $6.2M
Connections
Revenue to profitQ2 YE26
The operating loss was 7468% of revenue.
Who owns it
2funds